CENTENNIAL, Colo., June 17, 2019 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S. Food and Drug Administration's (FDA) approval ...
Cochlear Limited announced yesterday the U.S. Food and Drug Administration clearance of three new products to be added to the company’s suite of hearing technology devices, all of which can connect to ...
Engaging the brain’s plasticity by stimulating the locus coeruleus, a region in the brainstem, could be a clinically relevant approach to optimize the efficacy of cochlear implants in restoring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results